Wednesday, February 29, 2012 5:53:41 PM
For Arguements Sake -
Take what I am about to say with a large grain of salt. It is 100% speculation and mainly I am just curious as to what everyone else thinks;
With that being said, does it not appear to be a little against the grain for a company trying to strengthen it's financials to not file with the SEC on time? If you look at the previous filings they are all on an almost predictive schedule.
From an objective standpoint, would it be crazy to think that maybe their game plan has changed completely recently? They go PR silent, yet begin to tweet out of the blue the same day a "huge" product is supposed to go online. The main website is not promoting Spyder. I don't think it is a stretch to think maybe buyout/merger talks are, if nothing else, being discussed?
To be perfectly honest I do not know what to think, I am neutral but holding
Thoughts?
Dan
Take what I am about to say with a large grain of salt. It is 100% speculation and mainly I am just curious as to what everyone else thinks;
With that being said, does it not appear to be a little against the grain for a company trying to strengthen it's financials to not file with the SEC on time? If you look at the previous filings they are all on an almost predictive schedule.
From an objective standpoint, would it be crazy to think that maybe their game plan has changed completely recently? They go PR silent, yet begin to tweet out of the blue the same day a "huge" product is supposed to go online. The main website is not promoting Spyder. I don't think it is a stretch to think maybe buyout/merger talks are, if nothing else, being discussed?
To be perfectly honest I do not know what to think, I am neutral but holding
Thoughts?
Dan
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
